The HVTN is fortunate to work with a number of laboratories around the world, each with its area of specialty. In addition to the main laboratories listed here, HVTN involves additional labs for efficacy trials and for trials with unique requirements.
Duke University , Duke Human Vaccine Institute (Durham, NC)
PI: Georgia Tomaras
- Identifies and describes binding antibodies to HIV found in blood and tissue.
- Conducts research and development for the implementation of new laboratory tests to examine antibody responses.
PI: David Montefiori
- Identifies and describes neutralizing antibodies to HIV found in blood and tissue.
PI: Guido Ferrari
- Examines the role of antibodies in helping other parts of the immune system to kill HIV-infected cells, using specialized lab tests.
Fred Hutchinson Cancer Research Center, HVTN Immunology Laboratory (Seattle, WA)
PI: Julie McElrath
- Assesses cellular and innate immune responses in HIV vaccine trials.
- Conducts research and development for the implementation of new laboratory tests to examine cellular immune responses.
University of Washington, Virology Specialty Laboratory (Seattle, WA)
PI: Bob Coombs
- Performs HIV diagnostic testing for HVTN trials in the Americas.
Cape Town HVTN Immunology Laboratory (CHIL) (Cape Town, South Africa)
PI: Erica Andersen-Nissen
Assesses cellular and innate immune responses in HVTN vaccine trials.
Provides training to young African scientists to enhance laboratory skills needed for HIV vaccine research in Southern Africa.
National Institute of Communicable Diseases (Johannesburg, South Africa)
PI: Lynn Morris
- Identifies and describes neutralizing antibodies to HIV in HIV vaccine trials.
HIV Molecular and Serology Laboratories
PI: Adrian Puren
- Performs HIV diagnostic testing for HIV vaccine trials in South Africa.